CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AS ANTI-CANCER THERAPEUTICS
    4.
    发明申请
    CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AS ANTI-CANCER THERAPEUTICS 审中-公开
    作为抗癌治疗剂的CHIMERIC抗原受体表达T细胞

    公开(公告)号:US20150320799A1

    公开(公告)日:2015-11-12

    申请号:US14654227

    申请日:2013-12-20

    Abstract: Cytotoxic lymphocytes expressing chimeric antigen receptors (CAR) that target and bind small conjugate molecules (SCM) are disclosed, as well as methods of using the cells and the SCMs in the treatment of cancer.

    Abstract translation: 公开了靶向和结合小共轭分子(SCM)的表达嵌合抗原受体(CAR)的细胞毒性淋巴细胞,以及将细胞和SCM用于治疗癌症的方法。

Patent Agency Ranking